TuHURA Biosciences, Inc. (HURA) vs Spruce Biosciences, Inc. (SPRB)
A side-by-side comparison of TuHURA Biosciences, Inc. and Spruce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HURA
TuHURA Biosciences, Inc.
$1.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SPRB
Spruce Biosciences, Inc.
$42.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HURA vs SPRB
growth of $100 · dividends reinvested · last 6yHURA -97.8% (-47.2%/yr)SPRB -96.4% (-42.6%/yr)SPRB compounded faster over this window
HURA SPRB
HURA vs SPRB: by the numbers
- •HURA is the larger company ($124M vs $118M market cap).
Metrics side by side
Valuation
| Metric | HURA | SPRB |
|---|---|---|
| P/B ratio | 6.81 | 1.41 |
Profitability
| Metric | HURA | SPRB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -165.57% | -61.33% |
| ROIC | -137.40% | -50.67% |
Growth (annualized)
| Metric | HURA | SPRB |
|---|---|---|
| Total return CAGR (5Y) | -45.49% | -36.23% |
Frequently asked
- How have HURA and SPRB total returns compared?
- Over the past 5 years, HURA delivered -45.49% and SPRB delivered -36.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.